Drug Shortage Report for SANDOZ LISINOPRIL HCT

Last updated on 2024-12-02 History
Report ID 224639
Drug Identification Number 02302381
Brand name SANDOZ LISINOPRIL HCT
Common or Proper name LISINOPRIL HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE LISINOPRIL
Strength(s) 25MG 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30TAB
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2024-04-08
Estimated end date 2025-03-07
Actual end date
Shortage status Actual shortage
Updated date 2024-12-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-12-02 French Compare
v6 2024-12-02 English Compare
v5 2024-11-18 French Compare
v4 2024-11-18 English Compare
v3 2024-04-09 English Compare
v2 2024-04-08 French Compare
v1 2024-04-08 English Compare

Showing 1 to 7 of 7